Potent Preclinical Efficacy of DuoHexaBody-CD37 in B-Cell Malignancies.
Saved in:
| Title: | Potent Preclinical Efficacy of DuoHexaBody-CD37 in B-Cell Malignancies. |
|---|---|
| Authors: | van der Horst HJ; Department of Hematology, Cancer Center Amsterdam, Amsterdam UMC, VU Medical Center, Amsterdam, the Netherlands., Oostindie SC; Genmab, Utrecht, the Netherlands.; Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, the Netherlands., Cillessen SAGM; Department of Clinical Pathology, Amsterdam UMC, Amsterdam, the Netherlands., Gelderloos AT; Department of Hematology, Cancer Center Amsterdam, Amsterdam UMC, VU Medical Center, Amsterdam, the Netherlands., Overdijk MB; Genmab, Utrecht, the Netherlands., Nijhof IS; Department of Hematology, Cancer Center Amsterdam, Amsterdam UMC, VU Medical Center, Amsterdam, the Netherlands., Zweegman S; Department of Hematology, Cancer Center Amsterdam, Amsterdam UMC, VU Medical Center, Amsterdam, the Netherlands., Chamuleau MED; Department of Hematology, Cancer Center Amsterdam, Amsterdam UMC, VU Medical Center, Amsterdam, the Netherlands., Breij ECW; Genmab, Utrecht, the Netherlands., Mutis T; Department of Hematology, Cancer Center Amsterdam, Amsterdam UMC, VU Medical Center, Amsterdam, the Netherlands. |
| Source: | HemaSphere [Hemasphere] 2020 Dec 09; Vol. 5 (1), pp. e504. Date of Electronic Publication: 2020 Dec 09 (Print Publication: 2021). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Wiley Country of Publication: United States NLM ID: 101740619 Publication Model: eCollection Cited Medium: Internet ISSN: 2572-9241 (Electronic) Linking ISSN: 25729241 NLM ISO Abbreviation: Hemasphere Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 33324950 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Potent Preclinical Efficacy of DuoHexaBody-CD37 in B-Cell Malignancies. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22van+der+Horst+HJ%22">van der Horst HJ</searchLink>; Department of Hematology, Cancer Center Amsterdam, Amsterdam UMC, VU Medical Center, Amsterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Oostindie+SC%22">Oostindie SC</searchLink>; Genmab, Utrecht, the Netherlands.; Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Cillessen+SAGM%22">Cillessen SAGM</searchLink>; Department of Clinical Pathology, Amsterdam UMC, Amsterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Gelderloos+AT%22">Gelderloos AT</searchLink>; Department of Hematology, Cancer Center Amsterdam, Amsterdam UMC, VU Medical Center, Amsterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Overdijk+MB%22">Overdijk MB</searchLink>; Genmab, Utrecht, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Nijhof+IS%22">Nijhof IS</searchLink>; Department of Hematology, Cancer Center Amsterdam, Amsterdam UMC, VU Medical Center, Amsterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Zweegman+S%22">Zweegman S</searchLink>; Department of Hematology, Cancer Center Amsterdam, Amsterdam UMC, VU Medical Center, Amsterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Chamuleau+MED%22">Chamuleau MED</searchLink>; Department of Hematology, Cancer Center Amsterdam, Amsterdam UMC, VU Medical Center, Amsterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Breij+ECW%22">Breij ECW</searchLink>; Genmab, Utrecht, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Mutis+T%22">Mutis T</searchLink>; Department of Hematology, Cancer Center Amsterdam, Amsterdam UMC, VU Medical Center, Amsterdam, the Netherlands. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101740619%22">HemaSphere</searchLink> [Hemasphere] 2020 Dec 09; Vol. 5 (1), pp. e504. <i>Date of Electronic Publication: </i>2020 Dec 09 (<i>Print Publication: </i>2021). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley%22">Wiley </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101740619 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2572-9241 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2225729241%22">25729241 </searchLink><i>NLM ISO Abbreviation: </i>Hemasphere <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=33324950 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1097/HS9.0000000000000504 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: e504 Titles: – TitleFull: Potent Preclinical Efficacy of DuoHexaBody-CD37 in B-Cell Malignancies. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: van der Horst HJ – PersonEntity: Name: NameFull: Oostindie SC – PersonEntity: Name: NameFull: Cillessen SAGM – PersonEntity: Name: NameFull: Gelderloos AT – PersonEntity: Name: NameFull: Overdijk MB – PersonEntity: Name: NameFull: Nijhof IS – PersonEntity: Name: NameFull: Zweegman S – PersonEntity: Name: NameFull: Chamuleau MED – PersonEntity: Name: NameFull: Breij ECW – PersonEntity: Name: NameFull: Mutis T IsPartOfRelationships: – BibEntity: Dates: – D: 09 M: 12 Text: 2020 Dec 09 Type: published Y: 2020 Identifiers: – Type: issn-electronic Value: 2572-9241 Numbering: – Type: volume Value: 5 – Type: issue Value: 1 Titles: – TitleFull: HemaSphere Type: main |
| ResultId | 1 |